Analysis of Mutations in Pneumocystis jirovecii Dihydropteroate Synthase and Dihydropteroate Reductase Genes Among Non-HIV Patients in China
Our results implied that TMP-SMX prophylaxis is still recommended for PJP in high-risk non-HIV patients in China.
Authors
- Huiping Shi (ORCID: https://orcid.org/0000-0002-4727-9999)
- Guowei Yang (ORCID: https://orcid.org/0000-0002-3090-6677)
- Yuhan Shao
- Yun Wu (ORCID: https://orcid.org/0000-0001-6573-8354)
- Nicholas R. Waterfield (ORCID: https://orcid.org/0000-0002-8044-7763)
- Xia Rao (ORCID: https://orcid.org/0000-0001-6531-181X)
- Jian Li (ORCID: https://orcid.org/0000-0002-7521-8798)
- Wei Wang (ORCID: https://orcid.org/0000-0001-7492-6795)
- Y. An
Institutions
- Capital Medical University (CN)
- University of Warwick (GB)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/idr.s491478
- Citations
- 1
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Natural Science Foundation of China